SCHEMBL28795244

SCHEMBL28795244

COc1cc(N2CCC3(CC2)CN(C2CNC2)C3)c(C)cc1[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.38
SIRT6 Q8N6T7 1/20 0.38
KMT2A Q03164 2/20 0.37
HTT P42858 1/20 0.37
GAA P10253 1/20 0.36
MAPT P10636 6/20 0.35
DRD2 P14416 1/20 0.34
KDM4E B2RXH2 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29802995 0.93 ALDH1A1 (0.40) ALDH1A1LMNASMN1; SMN2SIRT6KMT2A
SCHEMBL28795481 0.89 ALDH1A1 (0.37) ALDH1A1LMNASMN1; SMN2SIRT6KMT2A
Trifluoroacetic Acid SCHEMBL28795110 0.86 FFAR4 (0.38) ALDH1A1LMNASMN1; SMN2SIRT6KMT2A
SCHEMBL28795201 0.84 ALDH1A1 (0.41) ALDH1A1LMNASMN1; SMN2SIRT6KMT2A
SCHEMBL29803025 0.84 ALDH1A1 (0.44) ALDH1A1LMNASMN1; SMN2SIRT6KMT2A
SCHEMBL22182766 0.84 ALDH1A1 (0.44) ALDH1A1LMNASMN1; SMN2SIRT6KMT2A
SCHEMBL29785394 0.84 SIRT6 (0.48) ALDH1A1LMNASMN1; SMN2SIRT6KMT2A
SCHEMBL22028007 0.84 SIRT6 (0.48) ALDH1A1LMNASMN1; SMN2SIRT6KMT2A
SCHEMBL28795309 0.83 ALDH1A1 (0.41) ALDH1A1LMNASMN1; SMN2SIRT6KMT2A
SCHEMBL29802998 0.83 DRD2 (0.41) ALDH1A1LMNASMN1; SMN2SIRT6KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114805303-A Molecule with double functions of degrading EGFR (epidermal growth factor receptor), composition and pharmaceutical application thereof 海思科医药集团股份有限公司 2022-07-29 CN disclosed